PuraPharm Corp. Ltd. (HK:1498) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PuraPharm Corp. Ltd. has announced a change in its auditor, replacing Ernst & Young with BDO Limited, due to more competitive proposals that promise enhanced corporate governance and cost-effectiveness. This shift follows EY’s resignation over a disagreement on audit fees for the upcoming fiscal year. The company assures that the transition will not impact its annual audit for FY2024.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.